Topic one: Shortage of drugs
Moderators
María Alonso Lilly Spain, Madrid
Camilla Appelgren Mannheimer Swartling, Stockholm
Ruta Pumputiene Ellex Valiunas, Lithuania
Topic two: The current surge and challenges of digital therapeutics
Moderators
Adem Koyuncu Covington, Brussels
Elisa Stefanini Portolano Cavallo, Milan
Cécile Théard-Jallu De Gaulle Fleurance & Associés, Paris
Topic three: Financing of advanced new therapies
Moderators
Mireia Castro Novartis Spain, Barcelona
Alfonso Gallego Pfizer, Madrid
Topic four: E-commerce of medicinal products: Global freedom or national restrictions?
Moderators
José Fernández Rañada Garrigues, Madrid
Markus Schott Bär & Karrer, Zurich
Dr Katharina Wodarz Raue, Berlin
Topic five: Product liability and medical devices
Moderators
Manuel Durães Rocha Abreu Advogados, Lisbon
Monika Gattiker Lanter, Zurich
Topic six: Gene therapies and orphan drugs - regulatory status and reimbursement
Moderators
Henar Álvarez Alnylam Pharmaceuticals, Madrid
Ariadna Padilla Takeda, Madrid
Topic seven: Re-labelling repackaging and parallel import of medical devices and pharmaceuticals
Moderators
Maria Cedó Esteve, Barcelona
Janine Demont-Reudt Niederer Kraft Frey, Zurich
Miguel Ángel Galve ex GC of Elanco, Madrid
Topic eight: Human research – big data and secondary use of data
Moderators
Beatriz Cocina Arrieta Uria Menendez, Madrid
Ioanna Michalopoulou Michalopoulou & Associates, Athens
Lincoln Tsang Ropes & Gray, London
Topic nine: Deal structures of life sciences transactions
Moderators
Gustavo Alcocer Lugo Olivares, México City
Elazar Stein Medison Pharma, Petach Tikva and Zug, Israel
Emmanuelle Trombe McDermott, Will & Emery, Paris
Topic ten: Interplay between regulation and intellectual property - review of Bolar exemption
Moderators
Rais Amils Pérez Llorca, Madrid
Özge Atilgan Karakulak Gün + Partners, Istanbul
Martin Dræbye Gantzhorn Bech-Bruun, Copenhagen
Topic eleven: Artificial intelligence and life sciences
Moderators
James Gallagher Mason Hayes & Curran, Dublin
Njeri Mutura Microsoft, Irvine, California
Josefine Sommer Sidley Austin LLP, Brussels
Topic twelve: Trade secrets / confidentiality in R&D collaborations
Moderators
Dr Hussein Akhavannik Blank Rome, Washington, District of Columbia
Maarten Schut Kennedy Van der Laan, Amsterdam
Topic thirteen: Recent landscape on foreign direct investment in medtech/pharma
Moderators
Per Lagerkvist MAQS, Stockholm
Irene Fernández Puyol Gómez-Acebo & Pombo, Madrid
Topic fourteen: Unified patent court – takeaways from the first year
Moderators
Morten Bruus Accura, Copenhagen
Francine Le Péchon-Joubert De Gaulle Fleurance, Paris
Hanna Tilus Cirio, Stockholm
Topic fifteen: Pharmaceuticals disparagement cases –Interactions with HCPs and regulators from a competition law perspective
Moderators
Luis Alcover Faus Moliner, Barcelona
Moisés Ramírez GSK Spain, Madrid
Anders Thue Simonsen Vogt Wiig, Oslo
Topic sixteen: Advertising pharmaceuticals - old law for modern information needs
Moderators
Ariadna Casanueva Cuatrecasas, Barcelona
Viviana Cervieri Cervieri Monsuárez, Montevideo
Celine Weber Walder Wyss, Zurich
Topic seventeen: Securing innovation: Tackling the 21st century epidemic of counterfeiting and intellectual property piracy
Moderators
Francisco Javier García Uría Menéndez, Barcelona
Jason Jardine Knobbe Martens, San Diego, California
Luis Ruiz BPL, Guatemala City